138 related articles for article (PubMed ID: 16296712)
21. Effect of metoprolol and amlodipine on myocardial total ischaemic burden in patients with stable angina pectoris.
Klein G; Pfafferott C; Beil S; Gehring J; Niemelä M; Kendall MJ
J Clin Pharm Ther; 1997; 22(5-6):371-8. PubMed ID: 19160722
[TBL] [Abstract][Full Text] [Related]
22. Antianginal efficacy over 24 hours and exercise hemodynamic effects of once daily sustained-release 300 mg diltiazem and 240 mg verapamil in stable angina pectoris.
De Rosa ML; Giordano A; Melfi M; Della Guardia D; Ciaburri F; Rengo F
Int J Cardiol; 1998 Jan; 63(1):27-35. PubMed ID: 9482142
[TBL] [Abstract][Full Text] [Related]
23. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
[TBL] [Abstract][Full Text] [Related]
24. Combination of calcium channel blockers and beta-adrenoceptor blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. Netherlands Working Group on Cardiovascular Research (WCN).
Van Der Vring JA; Daniëls MC; Holwerda NJ; Withagen PJ; Schelling A; Cleophas TJ; Hendriks MG
Br J Clin Pharmacol; 1999 May; 47(5):493-8. PubMed ID: 10336572
[TBL] [Abstract][Full Text] [Related]
25. Medical treatment of myocardial ischemia in coronary artery disease: effect of drug regime and irregular dosing in the CAPE II trial.
Deanfield JE; Detry JM; Sellier P; Lichtlen PR; Thaulow E; Bultas J; Brennan C; Young ST; Beckerman B;
J Am Coll Cardiol; 2002 Sep; 40(5):917-25. PubMed ID: 12225716
[TBL] [Abstract][Full Text] [Related]
26. [Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension].
Witkowska M; Tracz W; Kubler G; Negrusz-Kawecka M; Hlawaty M; Olszowska M; Salamon P
Przegl Lek; 1997; 54(5):324-8. PubMed ID: 9380807
[TBL] [Abstract][Full Text] [Related]
27. Usefulness of amlodipine for angina pectoris.
Taylor SH
Am J Cardiol; 1994 Jan; 73(3):28A-33A. PubMed ID: 8310973
[TBL] [Abstract][Full Text] [Related]
28. Amlodipine reduces transient myocardial ischemia in patients with coronary artery disease: double-blind Circadian Anti-Ischemia Program in Europe (CAPE Trial).
Deanfield JE; Detry JM; Lichtlen PR; Magnani B; Sellier P; Thaulow E
J Am Coll Cardiol; 1994 Nov; 24(6):1460-7. PubMed ID: 7930276
[TBL] [Abstract][Full Text] [Related]
29. [Effects of long-acting calcium antagonists--amlodipine and diltiazem in patients with stable angina of effort: comparative randomized controlled trial].
Martsevich SIu; Sementsov DP; Kutishenko NP; Alimova EV
Ter Arkh; 2001; 73(9):42-6. PubMed ID: 11642080
[TBL] [Abstract][Full Text] [Related]
30. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
31. The efficacy and safety of amlodipine in the treatment of mild and moderate essential hypertension in general practice.
Varrone J;
J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S30-3. PubMed ID: 16296705
[TBL] [Abstract][Full Text] [Related]
32. Open evaluation of amlodipine in the monotherapeutic treatment of systolic hypertension in the elderly.
Vandewoude MF; Lambert M; Vryens R
J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S28-9. PubMed ID: 16296704
[TBL] [Abstract][Full Text] [Related]
33. 24-hour blood pressure control with the once-daily calcium antagonist amlodipine.
Raftery EB; Heber ME; Brigden G; Al-Khawaja I
J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S8-12. PubMed ID: 16296698
[TBL] [Abstract][Full Text] [Related]
34. Amlodipine in hypertension: its effects on platelet aggregation and dynamic exercise.
Hernández R; Carvajal AR; Armas-de Hernande MJ; Guerrero-Pajuelo J; Armas-Padilla MC; Barragan O; Machado-de Alvarado I
J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S25-7. PubMed ID: 16296703
[TBL] [Abstract][Full Text] [Related]
35. Combination of calcium channel blockers and beta-blockers for patients with exercise-induced angina pectoris: beneficial effect of calcium channel blockers largely determined by their effect on heart rate.
Cleophas TJ; van der Sluijs J; van der Vring JA; Daniëls MC; Holwerda KJ; Withagen AJ; Schelling A; Hendriks MG; Zwinderman AH
J Clin Pharmacol; 1999 Jul; 39(7):738-46. PubMed ID: 10392329
[TBL] [Abstract][Full Text] [Related]
36. Antihypertensive efficacy of night-time graded-release diltiazem versus morning amlodipine in African Americans.
Wright JT; Sica DA; Gana TJ; Bohannon K; Pascual LG; Albert KS
Am J Hypertens; 2004 Sep; 17(9):734-42. PubMed ID: 15363813
[TBL] [Abstract][Full Text] [Related]
37. [Efficiency and safety of a long-lasting form of diltiazem in the treatment of hypertensive patients with ischemic heart disease].
Svetyĭ LI; Pavlova LI; Mazerkina IA
Klin Med (Mosk); 2002; 80(8):58-61. PubMed ID: 12360623
[TBL] [Abstract][Full Text] [Related]
38. Amlodipine once a day in stable angina: double-blind crossover comparison with placebo.
Deedwania PC; Cheitlin MD; Das SK; Pool PE; Singh JB; Pasternak RC
Clin Cardiol; 1993 Aug; 16(8):599-602. PubMed ID: 8370191
[TBL] [Abstract][Full Text] [Related]
39. Effect of amlodipine on 24-hour ambulatory blood pressure in hypertensive patients.
Mroczek WJ; Burris JF; Allenby KS
J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S13-5. PubMed ID: 16296699
[TBL] [Abstract][Full Text] [Related]
40. Amlodipine versus diltiazem CR in the reduction of the total ischemic burden: the Circadian Anti-Ischemia Program in Europe (CAPE) II trial--clinical rationale and methodology.
Deanfield JE
Cardiovasc Drugs Ther; 1998 Oct; 12 Suppl 3():239-42. PubMed ID: 9800053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
